Andra AP fonden Has $10.48 Million Stock Holdings in Corteva, Inc. $CTVA

Andra AP fonden trimmed its holdings in Corteva, Inc. (NYSE:CTVA) by 58.7% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 125,258 shares of the company’s stock after selling 178,132 shares during the quarter. Andra AP fonden’s holdings in Corteva were worth $10,485,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. increased its position in Corteva by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock valued at $5,398,392,000 after acquiring an additional 317,538 shares in the last quarter. State Street Corp increased its holdings in shares of Corteva by 3.7% in the fourth quarter. State Street Corp now owns 36,570,876 shares of the company’s stock valued at $2,451,346,000 after purchasing an additional 1,290,071 shares in the last quarter. Franklin Resources Inc. raised its position in Corteva by 4.3% in the 4th quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock worth $1,309,599,000 after purchasing an additional 805,873 shares during the last quarter. Harris Associates L P lifted its holdings in Corteva by 168.1% during the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after buying an additional 10,675,052 shares in the last quarter. Finally, Northern Trust Corp boosted its position in Corteva by 5.0% in the 4th quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock valued at $786,385,000 after buying an additional 562,550 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Price Performance

Corteva stock opened at $86.89 on Wednesday. The firm has a market capitalization of $58.11 billion, a P/E ratio of 51.11, a PEG ratio of 2.65 and a beta of 0.56. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $88.21. The business has a 50-day moving average of $81.03 and a 200-day moving average of $78.54. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. Corteva’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period last year, the company posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s dividend payout ratio (DPR) is presently 42.35%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on CTVA shares. BNP Paribas Exane boosted their target price on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Mizuho lifted their price objective on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 14th. Berenberg Bank boosted their price objective on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a report on Thursday, March 26th. Royal Bank Of Canada raised their target price on shares of Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a research note on Tuesday. Finally, Morgan Stanley lifted their price target on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.